TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Takeda Pharma A/S
Closing information (x1000 EUR)
| Closing information | 2025/03 | 2024/03 | 2023/03 |
| Turnover |
147,752
|
150,001
|
142,467 |
| Earnings before taxes |
2,298
|
45,016
|
2,799 |
| Total assets |
77,913
|
78,087
|
65,212 |
| Current assets |
75,467
|
73,346
|
55,074 |
| Current liabilities |
27,298
|
28,924
|
50,380 |
| Equity capital |
49,361
|
47,727
|
12,739 |
| - share capital |
1,354
|
1,354
|
1,356 |
| Employees (average) |
350
|
350
|
350 |
Financial ratios
| Fiscal year | 2025/03 | 2024/03 | 2023/03 |
| Solvency |
63.4%
|
61.1%
|
19.5% |
| Turnover per employee |
422
|
429
|
407 |
| Profit as a percentage of turnover |
1.6%
|
30.0%
|
2.0% |
| Return on assets (ROA) | |||
| Current ratio |
276.5%
|
253.6%
|
109.3% |
| Return on equity (ROE) |
4.7%
|
94.3%
|
22.0% |
| Change turnover |
-2,183
|
7,710
|
20,292 |
| Change turnover % |
-1%
|
5%
|
17% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/03 | 2024/03 | 2023/03 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.